Obermann, Mark <br/><br/>
Simultaneous early-onset immune thrombocytopenia and autoimmune thyroid disease following alemtuzumab treatment in relapsing-remitting multiple sclerosis.  [electronic resource] 

 -  Multiple sclerosis (Houndmills, Basingstoke, England)  08 2016 
 - 1235-41 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Review 
<br/><br/><label>ISSN: </label>1477-0970 
<br/><br/><label>Standard No.: </label>10.1177/1352458516638558  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Alemtuzumab--adverse effects<br/>Autoimmune Diseases--chemically induced<br/>Autoimmunity--drug effects<br/>Humans<br/>Immunosuppressive Agents--adverse effects<br/>Male<br/>Multiple Sclerosis, Relapsing-Remitting--diagnosis<br/>Purpura, Thrombocytopenic, Idiopathic--chemically induced<br/>Risk Factors<br/>Thyroid Diseases--chemically induced<br/>Time Factors<br/>Treatment Outcome